| Muscular Dystrophy |
1 |
1 |
| Cognition |
0 |
0.67 |
| Child |
0 |
0.98 |
| Revenue and Practice Management |
0 |
0.35 |
| Mild Cognitive Impairment |
0 |
0.34 |
| Cognitive Impairment |
0 |
0.99 |
| Hospital |
0 |
0.22 |
| Impairment |
0 |
0.22 |
| Preventive Screening |
0 |
0.22 |
| Virginia |
0 |
0.22 |
| Social Determinants of Health |
0 |
0.19 |
| Biologic Therapy |
0 |
0.11 |
| Cardiovascular Imaging |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Brain |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Colorado |
0 |
0.07 |
| Dementia |
0 |
0.07 |
| Disability |
0 |
0.07 |
| Dystrophinopathies |
0 |
0.07 |
| Ejection Fraction |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Memory |
0 |
0.07 |
| Neuropsychological Evaluation |
0 |
0.07 |
| Nutrition |
0 |
0.07 |
| Psychosocial |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Salary and Compensation |
0 |
0.07 |
| Socioeconomics |
0 |
0.07 |
| Weakness |
0 |
0.07 |